IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $83,000 | +822.2% | 12,653 | +275.3% | 0.00% | – |
Q1 2019 | $9,000 | -43.8% | 3,371 | 0.0% | 0.00% | – |
Q4 2018 | $16,000 | -50.0% | 3,371 | 0.0% | 0.00% | – |
Q3 2018 | $32,000 | -3.0% | 3,371 | 0.0% | 0.00% | – |
Q2 2018 | $33,000 | -13.2% | 3,371 | -5.2% | 0.00% | – |
Q1 2018 | $38,000 | +65.2% | 3,556 | 0.0% | 0.00% | – |
Q4 2017 | $23,000 | – | 3,556 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |